Shared Nearest Neighbors Approach and Interactive Browser for Network Analysis of a Comprehensive Non-Small-Cell Lung Cancer Data Set.


Journal

JCO clinical cancer informatics
ISSN: 2473-4276
Titre abrégé: JCO Clin Cancer Inform
Pays: United States
ID NLM: 101708809

Informations de publication

Date de publication:
07 2022
Historique:
entrez: 9 8 2022
pubmed: 10 8 2022
medline: 12 8 2022
Statut: ppublish

Résumé

Advances in biological measurement technologies are enabling large-scale studies of patient cohorts across multiple omics platforms. Holistic analysis of these data can generate actionable insights for translational research and necessitate new approaches for data integration and mining. We present a novel approach for integrating data across platforms on the basis of the shared nearest neighbors algorithm and use it to create a network of multiplatform data from the immunogenomic profiling of non-small-cell lung cancer project. Benchmarking demonstrates that the shared nearest neighbors-based network approach outperforms a traditional gene-gene network in capturing established interactions while providing new ones on the basis of the interplay between measurements from different platforms. When used to examine patient characteristics of interest, our approach provided signatures associated with and new leads related to recurrence and TP53 oncogenotype. The network developed offers an unprecedented, holistic view into immunogenomic profiling of non-small-cell lung cancer, which can be explored through the accompanying interactive browser that we built.

Identifiants

pubmed: 35944232
doi: 10.1200/CCI.22.00040
pmc: PMC9470146
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2200040

Subventions

Organisme : NCI NIH HHS
ID : P30 CA016672
Pays : United States
Organisme : NCI NIH HHS
ID : P50 CA070907
Pays : United States

Références

Genome Biol. 2017 May 5;18(1):83
pubmed: 28476144
Nat Commun. 2020 Jan 30;11(1):603
pubmed: 32001676
Sci Rep. 2017 Oct 17;7(1):13380
pubmed: 29042640
Cancer Discov. 2017 Aug;7(8):818-831
pubmed: 28572459
Bioinformatics. 2011 Jun 15;27(12):1739-40
pubmed: 21546393
Oncotarget. 2017 Jan 31;8(5):8921-8946
pubmed: 27888811
Ann Oncol. 2022 Jan;33(1):42-56
pubmed: 34653632
Nature. 2020 Feb;578(7793):82-93
pubmed: 32025007
Oncogene. 2015 Oct 29;34(44):5513-23
pubmed: 25728674
Cancers (Basel). 2018 Jun 27;10(7):
pubmed: 29954119
Hum Mutat. 2016 Sep;37(9):865-76
pubmed: 27328919
J Thorac Oncol. 2021 Jan;16(1):127-139
pubmed: 33096269
Curr Opin Biotechnol. 2020 Oct;65:284-295
pubmed: 32889231
Nat Methods. 2015 Mar;12(3):211-4, 3 p following 214
pubmed: 25581801
J Clin Oncol. 2016 Apr 10;34(11):1223-30
pubmed: 26834066
Nat Biotechnol. 2017 Aug;35(8):747-756
pubmed: 28714965
Nature. 2014 Sep 11;513(7517):S2-3
pubmed: 25208070
Cancer Discov. 2012 May;2(5):401-4
pubmed: 22588877
JAMA Oncol. 2021 Dec 01;7(12):1824-1832
pubmed: 34673888
Mol Cancer. 2015 Jul 31;14:145
pubmed: 26227631
Genome Biol. 2013 Apr 17;14(4):R32
pubmed: 23594524
Science. 2004 Nov 26;306(5701):1555-8
pubmed: 15567862
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
BMC Syst Biol. 2014;8 Suppl 2:I1
pubmed: 25032990
Nature. 2009 Nov 5;462(7269):108-12
pubmed: 19847166
Bioinformatics. 2022 Feb 18;:
pubmed: 35179562
Life Sci Alliance. 2019 Apr 12;2(2):
pubmed: 30979825
PLoS Med. 2016 Feb 16;13(2):e1001961
pubmed: 26881778
J Immunother Cancer. 2020 Apr;8(1):
pubmed: 32350118
Stat Appl Genet Mol Biol. 2005;4:Article17
pubmed: 16646834
Nat Genet. 2013 Oct;45(10):1113-20
pubmed: 24071849
Cell Death Differ. 2019 Jan;26(2):199-212
pubmed: 30538286
Nature. 2012 Sep 27;489(7417):519-25
pubmed: 22960745
Front Genet. 2017 Jun 16;8:84
pubmed: 28670325
Transl Lung Cancer Res. 2014 Aug;3(4):242-9
pubmed: 25806307

Auteurs

Stephanie T Schmidt (ST)

TRACTION Platform, Division of Therapeutics Discovery, The University of Texas MD Anderson Cancer Center, Houston, TX.

Neal Akhave (N)

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Ryan E Knightly (RE)

TRACTION Platform, Division of Therapeutics Discovery, The University of Texas MD Anderson Cancer Center, Houston, TX.

Alexandre Reuben (A)

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Natalie Vokes (N)

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Jianhua Zhang (J)

Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.

Jun Li (J)

Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.

Junya Fujimoto (J)

Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Lauren A Byers (LA)

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Beatriz Sanchez-Espiridion (B)

Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Lixia Diao (L)

Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Jing Wang (J)

Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Lorenzo Federico (L)

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Marie-Andree Forget (MA)

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Daniel J McGrail (DJ)

Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Annikka Weissferdt (A)

Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX.

Shiaw-Yih Lin (SY)

Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Younghee Lee (Y)

Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Erika Suzuki (E)

TRACTION Platform, Division of Therapeutics Discovery, The University of Texas MD Anderson Cancer Center, Houston, TX.

Jeffrey J Kovacs (JJ)

TRACTION Platform, Division of Therapeutics Discovery, The University of Texas MD Anderson Cancer Center, Houston, TX.

Carmen Behrens (C)

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Ignacio I Wistuba (II)

Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Andrew Futreal (A)

Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.

Ara Vaporciyan (A)

Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX.

Boris Sepesi (B)

Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX.

John V Heymach (JV)

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Chantale Bernatchez (C)

Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Cara Haymaker (C)

Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Tina Cascone (T)

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Jianjun Zhang (J)

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Christopher A Bristow (CA)

TRACTION Platform, Division of Therapeutics Discovery, The University of Texas MD Anderson Cancer Center, Houston, TX.

Timothy P Heffernan (TP)

TRACTION Platform, Division of Therapeutics Discovery, The University of Texas MD Anderson Cancer Center, Houston, TX.

Marcelo V Negrao (MV)

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Don L Gibbons (DL)

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH